Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhao-Ru Dong

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Cellular Physiology|November 17, 2018
The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA-342-3p target sequencePeng-Fei Zhang, Jing Wu, Yin Wu, et al.
Scientific Reports|June 21, 2016
Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinomaTao Li, Shu-Kang Wang, Xu-Ting Zhi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose-response meta-analysisLun-Jie Yan, Long-Shan Yang, Yu-Chuan Yan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 5, 2023
Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysisLong-Shan Yang, Lun-Jie Yan, Yu-Chuan Yan, et al.
Scientific Reports|July 21, 2015
TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resectionCheng-Hao Wang, Zhong-Yi Guo, Ze-Ting Chen, et al.
Heliyon|March 23, 2023
The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinomaGuang-Xiao Meng, Chun-Cheng Yang, Lun-Jie Yan, et al.
BMC Gastroenterology|August 28, 2019
Correction to: Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case reportZhao-Ru Dong, Yan-Ni Xia, Yue-Yi Zhao, et al.
BMC Gastroenterology|August 10, 2019
Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case reportZhao-Ru Dong, Yan-Ni Xia, Yue-Yi Zhao, et al.
Plos One|May 13, 2014
Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patientsXiao-Yong Huang, Chi Zhang, Jia-Bin Cai, et al.
International Journal of Surgery (London, England)|March 22, 2024
Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advancesDong-Xu Wang, Hui Liu, Jin-Cheng Tian, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Cellular Physiology|November 17, 2018
The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA-342-3p target sequencePeng-Fei Zhang, Jing Wu, Yin Wu, et al.
Scientific Reports|June 21, 2016
Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinomaTao Li, Shu-Kang Wang, Xu-Ting Zhi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose-response meta-analysisLun-Jie Yan, Long-Shan Yang, Yu-Chuan Yan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 5, 2023
Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysisLong-Shan Yang, Lun-Jie Yan, Yu-Chuan Yan, et al.
Scientific Reports|July 21, 2015
TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resectionCheng-Hao Wang, Zhong-Yi Guo, Ze-Ting Chen, et al.
Heliyon|March 23, 2023
The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinomaGuang-Xiao Meng, Chun-Cheng Yang, Lun-Jie Yan, et al.
BMC Gastroenterology|August 28, 2019
Correction to: Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case reportZhao-Ru Dong, Yan-Ni Xia, Yue-Yi Zhao, et al.
BMC Gastroenterology|August 10, 2019
Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case reportZhao-Ru Dong, Yan-Ni Xia, Yue-Yi Zhao, et al.
Plos One|May 13, 2014
Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patientsXiao-Yong Huang, Chi Zhang, Jia-Bin Cai, et al.
International Journal of Surgery (London, England)|March 22, 2024
Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advancesDong-Xu Wang, Hui Liu, Jin-Cheng Tian, et al.
Pageof 8